Updated 13 April 2017

Scientists trick body's viral response to combat cancer

If it is found that the therapy works, a new 'Trojan horse' method of attacking cancer could help pave the way to the highly-sought 'universal' treatment against all cancer types.


German researchers are presenting a Trojan horse method of attacking cancer, sneaking virus impersonators into the human body to unleash an anti-tumour immune offensive.

Simulated virus invasion

Tested in only three people so far, the treatment claims to be the latest advance in immunotherapy, which aims to rouse the body's own immune army against disease.

Made in the lab, this Trojan horse is composed of nanoparticles containing cancer RNA – a form of genetic coding – enclosed by a fatty acid membrane.

The particles are injected into patients to simulate a virus invasion, and infiltrate specialised immune cells.

Read: 16 tips on avoiding cancer

These so-called dendritic cells decode the RNA embedded in the nanoparticles – triggering, in turn, the production of cancer antigens.

The antigens then activate cancer-fighting T cells, and thus prime the body for an all-out, anti-tumour assault.

Following experiments in mice, three people with advanced skin cancer were given low doses of the treatment, in the first step of the long and cautious process to test new drugs on humans.

All developed a "strong" immune response, the team reported in the journal Nature.

Impressive immune responses

If further trials find the therapy works, they added, the method could help pave the way to the highly-sought "universal" treatment against all cancer types.

The new treatment is called an RNA vaccine – it works just like a preventive vaccine by mimicking an infectious agent and training the body to respond to it.

Read: Aspirin lowers risk of cancer

"Impressively, immune responses were observed" in the three cancer patients, expert commentators Jolanda de Vries and Carl Figdor of the Radboud University Medical Centre in Nijmegen in the Netherlands wrote in an analysis, also published by Nature.

But they cautioned "it is still early days, and a larger, randomised trial will be needed to validate these findings".

Immunotherapy is already used in treating some forms of cancer, but there is as yet no universal vaccine – the holy grail of cancer therapy.

Unlike viruses, bacteria or fungi which can be targeted with drugs, cancer cells are not intruders but our own cells gone haywire due to DNA damage.

Still a long way

This explains why they mostly circulate undisturbed by the body's immune system.

Read: Prevent cancer through nutrition

Finding drugs that can kill diseased cells without harming healthy ones has proven very difficult.

Chemotherapy, for example, targets fast-dividing cells – good and bad alike.

Immunotherapy seeks to activate the body's own immune response without killing healthy cells.

"Although the research is very interesting, it is still some way away from being of proven benefit to patients," immunotherapy professor Alan Melcher of The Institute of Cancer Research in London, told the Science Media Centre.

One outstanding issue was "the practical challenge of manufacturing nanoparticles for widespread clinical application".

Read more:

Symptoms of cancer

Types of cancer

Treating cancer


Ask the Expert

Cancer expert

CANSA’s purpose is to lead the fight against cancer in South Africa. Its mission is to be the preferred non-profit organisation that enables research, educates the public and provides support to all people affected by cancer. Questions are answered by CANSA’s Head of Health Professor Michael Herbst. For more information, visit

Still have a question?

Get free advice from our panel of experts

The information provided does not constitute a diagnosis of your condition. You should consult a medical practitioner or other appropriate health care professional for a physical exmanication, diagnosis and formal advice. Health24 and the expert accept no responsibility or liability for any damage or personal harm you may suffer resulting from making use of this content.

* You must accept our condition

Forum Rules